Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02625857
What this trial is testing

Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC 26
Early research (Phase 1)Looking for participantsNCT07493512
What this trial is testing

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Amgen 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04419402
What this trial is testing

Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 162
Not applicableLooking for participantsNCT04146077
What this trial is testing

Active Surveillance for Low Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
I.M. Sechenov First Moscow State Medical University 100
Large-scale testing (Phase 3)Study completedNCT00598312
What this trial is testing

Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Oakwood Laboratories, LLC 201
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757
What this trial is testing

Investigate APL-5125 in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more
Apollo Therapeutics Ltd 100
Large-scale testing (Phase 3)Looking for participantsNCT06320067
What this trial is testing

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
University College, London 3,360
Testing effectiveness (Phase 2)Ended earlyNCT00521781
What this trial is testing

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 14
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06044857
What this trial is testing

PSMA PET Response Guided SabR in High Risk Pca

Who this might be right for
Prostate Adenocarcinoma
University of Texas Southwestern Medical Center 20
Not applicableNot Yet RecruitingNCT07112612
What this trial is testing

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
MRDProstate CancermHSPC
Anhui Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00039624
What this trial is testing

Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT07288359
What this trial is testing

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 205
Not applicableUnknownNCT02651896
What this trial is testing

Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Hospital Sirio-Libanes 130
Not applicableStudy completedNCT01120262
What this trial is testing

S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 545
Not applicableUnknownNCT06497283
What this trial is testing

Binaural Sound for Remimazolam Maintenance

Who this might be right for
General AnesthesiaProstate Cancer StageUterine Myoma
Gangnam Severance Hospital 72
Not applicableLooking for participantsNCT06178354
What this trial is testing

Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer

Who this might be right for
Localized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+2 more
University of California, Davis 100
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Not applicableStudy completedNCT01640262
What this trial is testing

Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup

Who this might be right for
Prostatic Neoplasms
Copenhagen University Hospital at Herlev 170
Next Page